Abstract
This report analyzes the worldwide markets for Drug Discovery Technologies in
Millions of US$. The specific technology types analyzed are Bioanalytical
Instruments, High Throughput Screening (HTS), Biochip, Proteomics, Genomics,
Bioinformatics, and Pharmacogenomics. The report provides separate
comprehensive analytics for the US, Canada, Japan, Europe and Rest of World.
Annual forecasts are provided for each region for the period of 2001 through
2010. The report profiles 134 companies including many key and niche players
worldwide such as Abbott Laboratories, Affymetrix Inc., Agilent Technologies
Inc., Albany Molecular Research, Inc., Amersham Biosciences, Applera
Corporation, ArQule Inc., AstraZeneca, BD Biosciences, Bio-Rad Laboratories,
Inc., BioSciences Group, Caliper Life Sciences, Inc., Capital GenomiX, Caprion
Pharmaceuticals Inc., Charles River Laboratories International, Inc.,
ChemBridge Corporation, deCODE Genetics, Inc., Discovery Partners
International Inc., Evotec AG, ICOS Corporation, Incyte Corporation,
Inpharmatica, Invitrogen Corporation, Medarex, Inc., Merck & Co., Inc.,
Millennium Pharmaceuticals, Inc., National Center for Drug Screening,
PerkinElmer, Inc., Pharmacopeia Drug Discovery, Inc., Proteome Systems,
Quantum Pharmaceuticals, Shimadzu Corporation, Sigma-Aldrich, Tecan Group, and
Tripos, Inc. Market data and analytics are derived from primary and secondary
research. Company profiles are mostly extracted from URL research and reported
select online sources.
View Cart
